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Article: 
Although the effort of Valberg and Watson (1996) to incorporate epidemiologic data into an assessment of the 
plausibility of carcinogenicity estimates is to be commended, their analysis contains a fundamental 
flaw. The authors equate comparison of observed rates with expected rates, a common technique in 
epidemiology, to a comparison of the number of observed events with an expected number of events. The two 
comparisons are not equivalent. The only circumstance in which they are equivalent is when the same 
denominator of person-time produces both the observed and the expected events. 
 
More specifically, a standardized mortality or incidence ratio is calculated by: (1) stratifying on age, gender, 
and possibly other variables; (2) determining the stratum-specific observed number of events and the 
corresponding person-time that gave rise to those events; (3) calculating the comparable expected number of 
events based on the same person-time distribution (i.e., identical with respect to age, gender, etc., but differing 
with respect to an exposure of interest); (4) dividing the sum of the observed rates by the sum of the expected 
rates. When done correctly, one can re-place the rates with the number of events, since the denominators for 
both are identical. 
 
In comparing mortality predicted from animal data with mortality observed in an epidemiologic study, the same 
principle must apply: the expected number of events must be derived from the same ―person-time.’’ Valberg 
and Watson (1996) instead compared the lung cancer events observed in carbon black workers by 1980 (n = 13) 
with the expected number of events (n = 14.7) predicted for a population in which every subject is observed for 
an entire lifetime. This comparison is meaningless. Since only about 10% of the person-time was at ages >55 
years, few workers had reached the typically used 70- or 75-year ―lifetime.’’ In contrast, the unit risk derived 
using the rodent assay relates a quantified exposure to the probability of lung cancer death for a full lifetime. 
The fundamental point, which has been made previously (Hertz-Picciotto and Holtzman 1991; Hertz-Picciotto 
1995) but which is not well understood by risk assessors, is that the structure of data from an animal study 
differs from the structure of data from a human study: animals can be observed for their entire lifetime, while 
humans usually cannot. The data from an animal carcinogenicity bioassay are, therefore, ―lifetime risks’’ (the 
standard assumption is that a 2-year rat bioassay covers the animal lifetime), whereas the data from human 
studies are age-specific rates. 
 
After the last worker in the carbon black cohort either dies or reaches age 70, it will be possible to validly 
compare the observed number of deaths to the expected number of deaths. In the meantime, partial lifetime 
risks for the human population can be compared with animal-based risk estimates that have been scaled to 
partial lifetimes. 
 
How can this scaling be done? Clearly, most of the lifetime lung cancer deaths that will have occurred by the 
time the last worker reaches the age of 70 (or 75, or whatever is deemed to be a full lifetime) have simply not 
yet been observed. This problem is accentuated by the fact that the rise in lung cancer mortality with age is not 
linear, but is far steeper—approximately the fourth power of age. 
 
If one examines the pattern of human lung cancer mortality, one can estimate the proportion of lifetime risk that 
is incurred at any specific age. Using multiple decrement lifetables constructed from 1990 U.S. male lung 
cancer and all-cause mortality rates (the latter are used to correct for competing risks), we have calculated the 
proportion of cumulative lifetime risk experienced by persons of different ages. Allowing age 75 to represent 
the lifetime of risk that is of interest, the total accumulated risk for lung cancer mortality is 0.050; the 
accumulated risk by age 55 is 0.007, or about one-seventh of the total. Accordingly, the figure of 14.7 lung 
cancer deaths predicted by the animal bioassay should be divided by 7 to obtain the partial-lifetime-predicted 
number of deaths. 
 
Thus, to scale the animal predictions, one would need, at a minimum, the age distribution of the entire cohort at 
the end of follow-up. A predicted lung cancer risk for partial lifetime could then be calculated for each worker, 
and these could be summed for comparison with observed deaths. 
 
Other weaknesses in the analysis of Valberg and Watson stem from defects in the original analysis by 
Robertson and Ingalls (1980). For instance, because the follow-up time analyzed by these authors only included 
―active’’ person-years (years in which the workers were employed) and years after retirement, but not person-
years after a worker left employment at the plant for reasons other than retirement, their results are subject to 
strong bias from the healthy worker survivor effect (Fox and Collier, 1976; Pearce et al., 1986). It has been well 
established that workers who leave the work force are, in general, in poorer health than those who remain on the 
job, even after adjusting for age (Delzell and Monson, 1981; Arrighi and Hertz-Picciotto, 1994). Valberg and 
Watson also make assumptions about length of service that are not supported by the statements of Robertson 
and Ingalls, who assert that the average size of the workforce during the last 25 years of follow-up was 1250 
and that the turnover was 2% annually. These problems would also need to be ad-dressed in a proper analysis 
comparing the epidemio-logic data on carbon black workers with the animal-based predictions. 
 
Any comparison of human and animal data involves a degree of conjecture; nevertheless, since regulatory 
policy routinely assumes some comparability, the at-tempt to validate animal-based risk projections is a 
worthwhile venture, provided that it is done correctly. Direct comparisons of animal and human data can 
elucidate situations in which risks have been overestimated by extrapolation from animal experiments, e.g., 
ethylene dibromide (Hertz-Picciotto et al., 1988) and cadmium (Hertz-Picciotto and Hu, 1994). How-ever, 
without a comparison based on the age distribution of the carbon black cohort, it is not possible to know 
whether, in this case, the animal-based risk assessment overestimates human lung cancer mortality or not. 
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